Arrivent Biopharma Inc (AVBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 16,716 | 22,584 | 12,172 | 0 | 0 |
| Operating Income | -16,716 | -22,584 | -12,172 | N/A | N/A |
| Other Income | 2,315 | 1,017 | 0 | 0 | 0 |
| Pre-tax Income | -14,401 | -21,567 | -12,172 | 0 | 0 |
| Net Income Continuous | -14,401 | -21,567 | -12,172 | N/A | N/A |
| Net Income | $-14,401 | $-21,567 | $-12,172 | $N/A | $N/A |
| EPS Basic Total Ops | -5.52 | -10.79 | -9.45 | N/A | N/A |
| EPS Basic Continuous Ops | -5.52 | -10.78 | -9.45 | N/A | N/A |
| EPS Diluted Total Ops | -5.52 | -10.79 | -9.45 | N/A | N/A |
| EPS Diluted Continuous Ops | -5.52 | -10.78 | -9.45 | N/A | N/A |
| EBITDA(a) | $-16,716 | $-22,584 | $-12,172 | $N/A | $N/A |